AVB vs CNSP · P/E 23, rev $3.04B vs $6.6M cap
AvalonBay Communities Inc (AVB) versus CNS Pharmaceuticals Inc (CNSP) — a side-by-side from cached financials, not a winner call.
AvalonBay Communities Inc (AVB) is a reit - residential company listed on US.
CNS Pharmaceuticals Inc (CNSP) is a biotechnology company listed on NASDAQ.
Latest reported AVB revenue for 2025-12-31 was $3.04B. Net income was $1.06B. Revenue was up 4.4% from 2024-12-31 to 2025-12-31. AVB currently screens at market cap $26.84B and trailing P/E 23.4.
CNSP does not have a complete income-statement cache yet.
AVB currently screens at market cap $26.84B and trailing P/E 23.4. CNSP currently screens at market cap $6.6M.
Not investment advice. Open the AVB and CNSP stock pages for the full models.
Not investment advice.